Clinical trial
Influence of Intensive Lipid-lowering With Statin and Ezetimib Prescription on Computed Tomography Derived Fractional Flow Reserve in Patients With Stable Chest Pain (The FLOW-PROMOTE Study)
NCT04737408 is registered in ClinicalTrials.gov with Bjarne Linde Noergaard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Intensive Lipid-lowering With Statin and Ezetimib Prescription on Computed Tomography Derived Fractional Flow Reserve in Patients With Stable Chest Pain (The FLOW-PROMOTE Study)
- Lead sponsor
- Bjarne Linde Noergaard
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 13, 2020
- Completion date
- August 31, 2023
- Enrollment
- 120 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.